# International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

> **NCT04395768** · PHASE2 · UNKNOWN · sponsor: **National Institute of Integrative Medicine, Australia** · enrollment: 200 (estimated)

## Conditions studied

- COVID19

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin C
- **DRUG:** Hydroxychloroquine
- **DRUG:** Azithromycin
- **DIETARY_SUPPLEMENT:** Zinc Citrate
- **DIETARY_SUPPLEMENT:** Vitamin D3
- **DIETARY_SUPPLEMENT:** Vitamin B12

## Key facts

- **NCT ID:** NCT04395768
- **Lead sponsor:** National Institute of Integrative Medicine, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-09
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395768, "International ALLIANCE Study of Therapies to Prevent Progression of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04395768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*